PT Kalbe Farma Tbk 2023 SR
The report highlights PT Kalbe Farma Tbk's commitment to its 'Together Building a Healthy Nation' strategy through the SEHAT and ERAT sustainability pillars. In 2023, the company expanded access to healthcare by serving over 100 million patients with generic drugs and 100,000 cancer patients. Key environmental achievements include increasing solar panel capacity to 6.5 MWp and receiving a Gold PROPER award for the Cikarang site. The company also launched innovative products like INDIGEN, a locally produced TB diagnostic test, and Efesa, a domestic biologic drug for anemia. Social initiatives reached 400,000 children through stunting eradication programs.
Company: PT Kalbe Farma Tbk
Sector: Health Care
Country: Indonesia
Year: 2023
Type: SR
Pages: 120
Back to company
PT Kalbe Farma Tbk
Sustainability Report
The report highlights PT Kalbe Farma Tbk's commitment to its 'Together Building a Healthy Nation' strategy through the SEHAT and ERAT sustainability pillars. In 2023, the company expanded access to healthcare by serving over 100 million patients with generic drugs and 100,000 cancer patients. Key environmental achievements include increasing solar panel capacity to 6.5 MWp and receiving a Gold PROPER award for the Cikarang site. The company also launched innovative products like INDIGEN, a locally produced TB diagnostic test, and Efesa, a domestic biologic drug for anemia. Social initiatives reached 400,000 children through stunting eradication programs.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2023
Reporting Period
Jan 1, 2023 - Dec 31, 2023
Fiscal Year
2023
Published
Apr 24, 2024
Type
Sustainability Report
Language
English, Indonesian
Pages
File Size
Standards & Assurance
Reporting Standards
Materiality Assessment
Sustainable Development Goals
Other Standards
ESG Data?Experimental: AI-extracted data, may contain inaccuracies
Emissions
Scope 1:
Scope 2:
Energy Consumption
Renewable Energy
Water Consumption
Total Waste
Women on Board
Workplace Fatalities
Employees